Focus on the splicing of Secretin GPCRs transmembrane-domain 7

Trends in Biochemical Sciences

Volumn 34, Issue 9, 2009, Pages 443-452

  Markovic, Danijela ^a   Grammatopoulos, Dimitris K ^a  

^a Clinical Sciences Research Institute   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN RECEPTOR; CALCITONIN RECEPTOR LIKE RECEPTOR; CORTICOTROPIN RELEASING FACTOR; FRIZZLED PROTEIN; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON RECEPTOR; GLUTAMIC ACID; MESSENGER RNA PRECURSOR; PARATHYROID HORMONE; RHODOPSIN; SECRETIN;

ADHESION; ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; EXPRESSED SEQUENCE TAG; GENE MUTATION; GENE SEQUENCE; GENETIC CONSERVATION; HORMONE ACTION; HUMAN; MAMMAL CELL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN MOTIF; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; CONSERVED SEQUENCE; EXONS; HUMANS; MODELS, MOLECULAR; PHYLOGENY; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GASTROINTESTINAL HORMONE; RNA SPLICE SITES; SECRETIN; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 69949090808     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibs.2009.06.002     Document Type: Review

References (74)

1. Schellenberg M.J., et al. Pre-mRNA splicing: a complex picture in higher definition. Trends Biochem. Sci. 33 (2008) 243-246
2. Maniatis T., and Tasic B. Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature 418 (2002) 236-243
3. Sharp P.A. Split genes and RNA splicing. Cell 77 (1994) 805-815
4. Wang E.T., et al. Alternative isoform regulation in human tissue transcriptomes. Nature 456 (2008) 470-476
5. Xu Q., et al. Genome-wide detection of tissue-specific alternative splicing in the human transcriptome. Nucleic Acids Res. 30 (2002) 3754-3766
6. Lewis B.P., et al. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 189-192
7. Kreth S., et al. Differential expression of 5′-UTR splice variants of the adenosine A2A receptor gene in human granulocytes: identification, characterization, and functional impact on activation. FASEB J. 22 (2008) 3276-3286
8. Monsma Jr. F.J., et al. Multiple D2 dopamine receptors produced by alternative RNA splicing. Nature 342 (1989) 926-929
9. Gentles A.J., and Karlin S. Why are human G-protein-coupled receptors predominantly intronless?. Trends Genet. 15 (1999) 47-49
10. Valencia P., et al. Splicing promotes rapid and efficient mRNA export in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 3386-3391
11. Wang G.S., and Cooper T.A. Splicing in disease: disruption of the splicing code and the decoding machinery. Nat. Rev. Genet. 8 (2007) 749-761
12. Srebrow A., and Kornblihtt A.R. The connection between splicing and cancer. J. Cell Sci. 119 (2006) 2635-2641
13. Kishore S., and Stamm S. The snoRNA HBII-52 regulates alternative splicing of the serotonin receptor 2C. Science 311 (2006) 230-232
14. Einstein R., et al. Alternative splicing of the G protein-coupled receptor superfamily in human airway smooth muscle diversifies the complement of receptors. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 5230-5235
15. Laitinen T., et al. Characterization of a common susceptibility locus for asthma-related traits. Science 304 (2004) 300-304
16. Bertolino A., et al. Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. Brain 32 (2009) 417-425
17. Sarzani R., et al. Altered pattern of cannabinoid type 1 receptor expression in adipose tissue of dysmetabolic and overweight patients. Metabolism 58 (2009) 361-367
18. Sztainberg Y., et al. A novel corticotropin-releasing factor receptor splice variant exhibits dominant negative activity: a putative link to stress-induced heart disease. FASEB J. 23 (2009) 2186-2196
19. Fredriksson R., et al. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. Mol. Pharmacol. 63 (2003) 1256-1272
20. Kilpatrick G.J., et al. 7TM receptors: the splicing on the cake. Trends Pharmacol. Sci. 20 (1999) 294-301
21. Bockaert J., and Pin J.P. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. 18 (1999) 1723-1729
22. Minneman K.P. Splice variants of GPCRs. Molecular Interventions 1 (2001) 108-116
23. Blondel O., et al. Cloning, expression, and pharmacology of four human 5-hydroxytryptamine 4 receptor isoforms produced by alternative splicing in the carboxyl terminus. J. Neurochem. 70 (1998) 2252-2261
24. Spengler D., et al. Differential signal transduction by five splice variants of the PACAP receptor. Nature 365 (1993) 170-175
25. Harmar, A.J. (2001) Family-B G-protein-coupled receptors. Genome Biol. 2, 3013.1-3013.10
26. Nordström K.J., et al. The Secretin GPCRs descended from the family of Adhesion GPCRs. Mol. Biol. Evol. 26 (2009) 71-84
27. Xiong Y., et al. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors: decreased coupling efficiency of human type II CRF receptor. Endocrinology 136 (1995) 1828-1834
28. Gorn A.H., et al. Expression of two human skeletal calcitonin receptor isoforms cloned from a giant cell tumor of bone. The first intracellular domain modulates ligand binding and signal transduction. J. Clin. Invest. 95 (1995) 2680-2691
29. Markovic D., et al. Differential responses of corticotropin-releasing hormone receptor type 1 variants to protein kinase C phosphorylation. J. Pharmacol. Exp. Ther. 319 (2006) 1032-1042
30. Nicot A., and DiCicco-Bloom E. Regulation of neuroblast mitosis is determined by PACAP receptor isoform expression. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 4758-4763
31. Harada N., et al. A novel GIP receptor splice variant influences GIP sensitivity of pancreatic β-cells in obese mice. Am. J. Physiol. Endocrinol. Metab. 294 (2008) E61-E68
32. Nag K., et al. Headless splice variant acting as dominant negative calcitonin receptor. Biochem. Biophys. Res. Commun. 362 (2007) 1037-1043
33. Pisarchik A., and Slominski A. Molecular and functional characterization of novel CRFR1 isoforms from the skin. Eur. J. Biochem. 271 (2004) 2821-2830
34. Chen A.M., et al. A soluble mouse brain splice variant of type 2alpha corticotropin-releasing factor (CRF) receptor binds ligands and modulates their activity. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2620-2625
35. Grammatopoulos D.K., et al. A novel spliced variant of the type 1 corticotropin-releasing hormone receptor with a deletion in the seventh transmembrane domain present in the human pregnant term myometrium and fetal membranes. Mol. Endocrinol. 13 (1999) 2189-2202
36. Ding C., et al. Identification of an alternative spliced form of PTH/PTHrP receptor mRNA in immrtalized renal tubular cells J. Bone Miner. Res. 10 suppl. 1 (1995) S484
37. Shyu J.F., et al. The deletion of 14 amino acids in the seventh transmembrane domain of a naturally occurring calcitonin receptor isoform alters ligand binding and selectively abolishes coupling to phospholipase C. J. Biol. Chem. 271 (1996) 31127-31134
38. Grinninger C., et al. A natural variant type II G protein-coupled receptor for vasoactive intestinal peptide with altered function. J. Biol. Chem. 279 (2004) 40259-40262
39. Vanti W.B., et al. Novel human G-protein-coupled receptors. Biochem. Biophys. Res. Commun. 305 (2003) 67-71
40. Harikumar K.G., et al. Transmembrane segment IV contributes a functionally important interface for oligomerization of the class II G Protein-coupled Secretin receptor. J. Biol. Chem. 282 (2007) 30363-30372
41. Harikumar K.G., et al. Pattern of intra-family hetero-oligomerization involving the G-protein-coupled Secretin receptor. J. Mol. Neurosci. 36 (2008) 279-285
42. Markovic D., et al. Structural determinants critical for localization and signaling within the seventh transmembrane domain of the type 1 corticotropin releasing hormone receptor: lessons from the receptor variant R1d. Mol. Endocrinol. 22 (2008) 2505-2519
43. Zmijewski M.A., and Slominski A.T. CRF1 receptor splicing in epidermal keratinocytes: potential biological role and environmental regulations. J. Cell Physiol. 218 (2008) 593-602
44. Seck T., et al. The Δe13 isoform of the calcitonin receptor forms a six transmembrane domain receptor with dominant negative effects on receptor surface expression and signaling. Mol. Endocrinol. 19 (2004) 2132-2144
45. Achour L., et al. An escort for GPCRs: implications for regulation of receptor density at the cell surface. Trends Pharmacol. Sci. 29 (2008) 528-535
46. Bulenger S., et al. Emerging role of homo- and heterodimerization in G-protein-coupled receptor biosynthesis and maturation. Trends Pharmacol. Sci. 26 (2005) 131-137
47. Conner A.C., et al. Heterodimers and family-B GPCRs: RAMPs, CGRP and adrenomedullin. Biochem. Soc. Trans. 32 (2004) 843-846
48. Christopoulos A., et al. Novel receptor partners and function of receptor activity-modifying proteins. J. Biol. Chem. 278 (2003) 3293-3297
49. Tan C.M., et al. Membrane trafficking of G protein-coupled receptors. Annu. Rev. Pharmacol. Toxicol. 44 (2004) 559-609
50. Duvernay M.T., et al. The regulatory mechanisms of export trafficking of G protein-coupled receptors. Cell. Signal. 17 (2005) 1457-1465
51. Bermak J.C., et al. Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein. Nat. Cell Biol. 3 (2001) 492-498
52. Duvernay M.T., et al. Anterograde trafficking of G protein-coupled receptors: function of the C-terminal F(X)6LL motif in export from the endoplasmic reticulum. Mol. Pharmacol. 75 (2009) 751-761
53. Duvernay M.T., et al. A single conserved leucine residue on the first intracellular loop regulates ER export of G protein-coupled receptors. Traffic 10 (2009) 552-566
54. Zhou F., et al. Cell-surface targeting of alpha2-adrenergic receptors -- inhibition by a transport deficient mutant through dimerization. Cell. Signal. 18 (2006) 318-327
55. Lisenbee C.S., and Miller L.J. Secretin receptor oligomers form intracellularly during maturation through receptor core domains. Biochemistry 45 (2006) 8216-8226
56. Donnelly D. The arrangement of the transmembrane helices in the Secretin receptor family of G-protein-coupled receptors. FEBS Lett. 409 (1997) 431-436
57. Schwartz T.W., et al. Molecular mechanism of 7TM receptor activation--a global toggle switch model. Annu. Rev. Pharmacol. Toxicol. 46 (2006) 481-519
58. Salahpour A., et al. Homodimerization of the β2-adrenergic receptor as a prerequisite for cell surface targeting. J. Biol. Chem. 279 (2004) 33390-33397
59. Ulloa-Aguirre A., and Conn P.M. Targeting of G protein-coupled receptors to the plasma membrane in health and disease. Front. Biosci. 14 (2009) 973-994
60. Conn P.M., and Janovick J.A. Drug development and the cellular quality control system. Trends Pharmacol. Sci. 30 (2009) 228-233
61. Blencowe B.J. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem. Sci. 25 (2000) 106-110
62. Sanford J.R., et al. Reversible phosphorylation differentially affects nuclear and cytoplasmic functions of splicing factor 2/alternative splicing factor. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 15042-15047
63. Patel N.A., et al. Insulin regulates alternative splicing of protein kinase C beta II through a phosphatidylinositol 3-kinase-dependent pathway involving the nuclear serine/arginine-rich splicing factor, SRp40, in skeletal muscle cells. J. Biol. Chem. 276 (2001) 22648-22654
64. Hagiwara M. Alternative splicing: a new drug target of the post-genome era. Biochim. Biophys. Acta 1754 (2005) 324-331
65. Markovic D., et al. The onset of labor alters corticotropin-releasing hormone type 1 receptor variant expression in human myometrium: putative role of interleukin-1beta. Endocrinology 148 (2007) 3205-3213
66. Tyson-Capper A.J. Alternative splicing: an important mechanism for myometrial gene regulation that can be manipulated to target specific genes associated with preterm labour. BMC Pregnancy Childbirth. 7 suppl. 1 (2007) S13
67. Kronenberg H.M. PTHrP and skeletal development. Ann. NY. Acad. Sci. 1068 (2006) 1-13
68. Charmandari E., et al. Endocrinology of the stress response. Annu. Rev. Physiol. 67 (2005) 259-284
69. Kuperman Y., and Chen A. Urocortins: emerging metabolic and energy homeostasis perspectives. Trends Endocrinol. Metab. 19 (2008) 122-129
70. Grammatopoulos D.K., and Chrousos G.P. Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists. Trends Endocrinol. Metab. 13 (2002) 436-444
71. Gautier J.F., et al. Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes. Diabetes Metab. 34 suppl. 2 (2008) S65-S72
72. Márquez-Rodas I., et al. Pathophysiology and therapeutic possibilities of calcitonin gene-related peptide in hypertension. J Physiol Biochem. 62 (2006) 45-56
73. Huang M.C., et al. Differential signaling of T cell generation of IL-4 by wild-type and short-deletion variant of type 2 G protein-coupled receptor for vasoactive intestinal peptide (VPAC2). J. Immunol. 176 (2006) 6640-6646
74. Rovati G.E., et al. The highly conserved DRY motif of class A G protein-coupled receptors: beyond the ground state. Mol. Pharmacol. 71 (2007) 959-964